[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Infantile Spasm (West Syndrome) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 32 pages | ID: IED61C90338EN
VPAResearch

US$ 630.00 US$ 700.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Infantile Spasm (West Syndrome) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Infantile Spasm (West Syndrome) disease clinical trials. The research work analyzes the ongoing Infantile Spasm (West Syndrome) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Infantile Spasm (West Syndrome) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Infantile Spasm (West Syndrome) clinical trials.

Scope of the Report-
  • Ongoing Infantile Spasm (West Syndrome) clinical trials across regions
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Infantile Spasm (West Syndrome)
  • Both observational and interventional trials analyzed
  • Leading companies and universities participating in Infantile Spasm (West Syndrome) clinical trials
Reasons to Buy
  • Track competition and design competitive advantages
  • Identify right partners to associate with for further research
  • Evaluate potential opportunities available in further clinical trials of the disease
  • Formulate business development strategies through success rates of clinical trials
  • Identify quick markets for recruiting subjects based on trials count by each market
1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Infantile Spasm (West Syndrome) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Infantile Spasm (West Syndrome) Trials by Phase
3.2 Ongoing Infantile Spasm (West Syndrome) Trials by Type
3.3 Ongoing Infantile Spasm (West Syndrome) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Infantile Spasm (West Syndrome) Trials
4.2 Top 10 Countries conducting Infantile Spasm (West Syndrome) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Infantile Spasm (West Syndrome) Trials by Sponsor Type
5.2 Infantile Spasm (West Syndrome) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Infantile Spasm (West Syndrome) Trials by year
6.2 Subjects Recruited for Infantile Spasm (West Syndrome) Trials by Phase
6.3 Subjects Recruited for Infantile Spasm (West Syndrome) Trials by Trial Type
6.4 Subjects Recruited for Infantile Spasm (West Syndrome) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Infantile Spasm (West Syndrome) Trials- Phase
7.2 Ongoing Infantile Spasm (West Syndrome) Trials- Phase
7.3 Ongoing Infantile Spasm (West Syndrome) Trials- Phase
7.4 Ongoing Infantile Spasm (West Syndrome) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

LIST OF FIGURES

Figure 1: Infantile Spasm (West Syndrome)- Clinical Trials by Country
Figure 2: Infantile Spasm (West Syndrome)- Clinical Trials by Phase of Development, 2018
Figure 3: Infantile Spasm (West Syndrome)- Clinical Trials by Status, 2018
Figure 4: Infantile Spasm (West Syndrome)- Clinical Trials by Type, 2018
Figure 5: Infantile Spasm (West Syndrome)- Clinical Trials Split by Region, 2000-2018
Figure 6: Infantile Spasm (West Syndrome)- Clinical Trials by Type of Economy, 2018
Figure 7: Infantile Spasm (West Syndrome)- Enrolment by Phase, 2018
Figure 8: Infantile Spasm (West Syndrome)- Enrolment by Trial Type, 2018
Figure 9: Infantile Spasm (West Syndrome)- Enrolment by Recruitment Status, 2018
Figure 10: Infantile Spasm (West Syndrome)- Clinical Trials by Sponsor Type, 2018
Figure 11: Infantile Spasm (West Syndrome)- Enrolment by Type of Sponsors
Figure 12: Infantile Spasm (West Syndrome)- Enrolment by Leading Sponsors

LIST OF TABLES

Table 1: Infantile Spasm (West Syndrome)- Clinical Trials by Sponsor Type, 2018
Table 2: Infantile Spasm (West Syndrome)- Clinical Trials by Economy Type, 2018
Table 3: Infantile Spasm (West Syndrome)- Clinical Trials by Region, 2018
Table 4: Infantile Spasm (West Syndrome)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Infantile Spasm (West Syndrome)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Infantile Spasm (West Syndrome)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Infantile Spasm (West Syndrome)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Infantile Spasm (West Syndrome)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Infantile Spasm (West Syndrome)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company


More Publications